title: Effects of hydrophilic and lipophilic beta-blockers on heart rate variability and baroreflex sensitivity in normal subjects.
abstract: To evaluate the effect of a hydrophilic and a lipophilic beta-blocker on the autonomic nervous system, 20 normal subjects were studied under baseline conditions and 7 days after being randomly assigned to metoprolol (200 mg/day), nadolol (80 mg/day), and placebo. Under each condition, the time-domain parameters were analyzed by means of 24-hour ECG monitoring and the frequency-domain parameters by means of the autoregressive method using 10-minute ECGs during rest, controlled respiration, and after a head-up tilt test. The alpha index (the gain in the relationship between the RR period and systolic arterial pressure variability) was also calculated. Both nadolol and metoprolol significantly increased all of the time-domain parameters except the standard deviation of the RH intervals; they also modified the frequency-domain parameters. Both blunted the significant reduction in the high frequency (HF) component and alpha index during tilt. In normal subjects, hydrophilic and lipophilic beta-blockers similarly modify the time- and frequency-domain parameters that are particularly evident when high sympathetic tone is present (during daytime and tilt). The value of the alpha index was increased by both beta-blockers in the HF, but not in the low frequency band; this difference might be due to the fact that the former is a measure of the vagal component of the baroreflex control and the latter a measure of the sympathetic component. The effects of hydrophilic and lipophilic beta-blockers on the time- and frequency-domain parameters of heart rate variability are similar.
authors.affiliation: Institute of Cardiology, University of Bari, Italy. pitzalis@mbox.vol.it
authors.forename: M V
authors.initials: MV
authors.lastname: Pitzalis
authors.forename: F
authors.initials: F
authors.lastname: Mastropasqua
authors.forename: F
authors.initials: F
authors.lastname: Massari
authors.forename: C
authors.initials: C
authors.lastname: Forleo
authors.forename: A
authors.initials: A
authors.lastname: Passantino
authors.forename: R
authors.initials: R
authors.lastname: Colombo
authors.forename: P
authors.initials: P
authors.lastname: Totaro
authors.forename: P
authors.initials: P
authors.lastname: Rizzon
mesh_terms: D000319:Adrenergic beta-Antagonists / Q000494:pharmacology*; D000328:Adult; D001341:Autonomic Nervous System / Q000187:drug effects* / Q000502:physiology; D017704:Baroreflex / Q000187:drug effects / Q000502:physiology*; D001794:Blood Pressure; D002940:Circadian Rhythm / Q000502:physiology; D018592:Cross-Over Studies; D015716:Electrocardiography, Ambulatory; D005260:Female; D005500:Follow-Up Studies; D006321:Heart / Q000294:innervation*; D006339:Heart Rate / Q000187:drug effects / Q000502:physiology*; D006801:Humans; D008297:Male; D008790:Metoprolol / Q000494:pharmacology*; D009248:Nadolol / Q000494:pharmacology*; D012119:Respiration / Q000502:physiology; D016037:Single-Blind Method; D018667:Tilt-Table Test; D013996:Time and Motion Studies
chemical_list: D000319:Adrenergic beta-Antagonists; D009248:Nadolol; D008790:Metoprolol